Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma - Annals of Surgical Oncology Background The management of invasive intraductal papillary mucinous cystic neoplasm (I-IPMN) does not differ from de novo pancreatic ductal adenocarcinoma (PDAC); however, I-IPMNs are debated to have...

Annals of Surgical Oncology repost:

Featured: Outcomes of #NeoadjuvantChemotherapy for Invasive Intraductal Papillary #MucinousNeoplasm Compared with de Novo #PancreaticAdenocarcinoma.

ow.ly/IL5g50Ui7Xa